 | • レポートコード：D005-00439 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ゲノムバイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。ゲノムバイオマーカーの種類別市場規模（腫瘍学、心臓学、神経学、腎臓学）、用途別市場規模（病院、診断・研究室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bio-Rad、Almac、Thermo Fisher Scientific、Beckman Coulter、Epigenomics、Myriad Genetics、Human Longevity、QIAGEN、Roche、Pfizer、Agilent、ValiRx、Illumina、Empire Genomics、Personalis、Eagle Genomics ・地域別グローバル市場分析 2015年-2020年 ・ゲノムバイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・ゲノムバイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ゲノムバイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ゲノムバイオマーカーの南米市場（ブラジル、アルゼンチン） ・ゲノムバイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腫瘍学、心臓学、神経学、腎臓学 ・用途別分析：病院、診断・研究室 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Genomic Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Genomic Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Genomic Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Genomic Biomarker market has been segmented into:
Oncology
Cardiology
Neurology
Nephrology
By Application, Genomic Biomarker has been segmented into:
Hospitals
Diagnostic and research laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Genomic Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Genomic Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genomic Biomarker market.
The report offers in-depth assessment of the growth and other aspects of the Genomic Biomarker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Genomic Biomarker Market Share Analysis
Genomic Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genomic Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genomic Biomarker sales, revenue and market share for each player covered in this report.
The major players covered in Genomic Biomarker are:
Bio-Rad
Almac
Thermo Fisher Scientific
Beckman Coulter
Epigenomics
Myriad Genetics
Human Longevity
QIAGEN
Roche
Pfizer
Agilent
ValiRx
Illumina
Empire Genomics
Personalis
Eagle Genomics
Table of Contents
1 Genomic Biomarker Market Overview
1.1 Product Overview and Scope of Genomic Biomarker
1.2 Classification of Genomic Biomarker by Type
1.2.1 Global Genomic Biomarker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Genomic Biomarker Revenue Market Share by Type in 2019
1.2.3 Oncology
1.2.4 Cardiology
1.2.5 Neurology
1.2.6 Nephrology
1.3 Global Genomic Biomarker Market by Application
1.3.1 Overview: Global Genomic Biomarker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Global Genomic Biomarker Market by Regions
1.4.1 Global Genomic Biomarker Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Genomic Biomarker (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Genomic Biomarker Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Genomic Biomarker Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomic Biomarker Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Genomic Biomarker Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomic Biomarker Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bio-Rad
2.1.1 Bio-Rad Details
2.1.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bio-Rad SWOT Analysis
2.1.4 Bio-Rad Product and Services
2.1.5 Bio-Rad Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.2 Almac
2.2.1 Almac Details
2.2.2 Almac Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Almac SWOT Analysis
2.2.4 Almac Product and Services
2.2.5 Almac Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Thermo Fisher Scientific SWOT Analysis
2.3.4 Thermo Fisher Scientific Product and Services
2.3.5 Thermo Fisher Scientific Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beckman Coulter SWOT Analysis
2.4.4 Beckman Coulter Product and Services
2.4.5 Beckman Coulter Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.5 Epigenomics
2.5.1 Epigenomics Details
2.5.2 Epigenomics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Epigenomics SWOT Analysis
2.5.4 Epigenomics Product and Services
2.5.5 Epigenomics Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Myriad Genetics SWOT Analysis
2.6.4 Myriad Genetics Product and Services
2.6.5 Myriad Genetics Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.7 Human Longevity
2.7.1 Human Longevity Details
2.7.2 Human Longevity Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Human Longevity SWOT Analysis
2.7.4 Human Longevity Product and Services
2.7.5 Human Longevity Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 QIAGEN SWOT Analysis
2.8.4 QIAGEN Product and Services
2.8.5 QIAGEN Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.11 Agilent
2.11.1 Agilent Details
2.11.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Agilent SWOT Analysis
2.11.4 Agilent Product and Services
2.11.5 Agilent Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.12 ValiRx
2.12.1 ValiRx Details
2.12.2 ValiRx Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ValiRx SWOT Analysis
2.12.4 ValiRx Product and Services
2.12.5 ValiRx Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.13 Illumina
2.13.1 Illumina Details
2.13.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Illumina SWOT Analysis
2.13.4 Illumina Product and Services
2.13.5 Illumina Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.14 Empire Genomics
2.14.1 Empire Genomics Details
2.14.2 Empire Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Empire Genomics SWOT Analysis
2.14.4 Empire Genomics Product and Services
2.14.5 Empire Genomics Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.15 Personalis
2.15.1 Personalis Details
2.15.2 Personalis Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Personalis SWOT Analysis
2.15.4 Personalis Product and Services
2.15.5 Personalis Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.16 Eagle Genomics
2.16.1 Eagle Genomics Details
2.16.2 Eagle Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Eagle Genomics SWOT Analysis
2.16.4 Eagle Genomics Product and Services
2.16.5 Eagle Genomics Genomic Biomarker Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Genomic Biomarker Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Genomic Biomarker Players Market Share
3.2.2 Top 10 Genomic Biomarker Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Genomic Biomarker Revenue and Market Share by Regions
4.2 North America Genomic Biomarker Revenue and Growth Rate (2015-2020)
4.3 Europe Genomic Biomarker Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Genomic Biomarker Revenue and Growth Rate (2015-2020)
4.5 South America Genomic Biomarker Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Genomic Biomarker Revenue and Growth Rate (2015-2020)
5 North America Genomic Biomarker Revenue by Countries
5.1 North America Genomic Biomarker Revenue by Countries (2015-2020)
5.2 USA Genomic Biomarker Revenue and Growth Rate (2015-2020)
5.3 Canada Genomic Biomarker Revenue and Growth Rate (2015-2020)
5.4 Mexico Genomic Biomarker Revenue and Growth Rate (2015-2020)
6 Europe Genomic Biomarker Revenue by Countries
6.1 Europe Genomic Biomarker Revenue by Countries (2015-2020)
6.2 Germany Genomic Biomarker Revenue and Growth Rate (2015-2020)
6.3 UK Genomic Biomarker Revenue and Growth Rate (2015-2020)
6.4 France Genomic Biomarker Revenue and Growth Rate (2015-2020)
6.5 Russia Genomic Biomarker Revenue and Growth Rate (2015-2020)
6.6 Italy Genomic Biomarker Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Genomic Biomarker Revenue by Countries
7.1 Asia-Pacific Genomic Biomarker Revenue by Countries (2015-2020)
7.2 China Genomic Biomarker Revenue and Growth Rate (2015-2020)
7.3 Japan Genomic Biomarker Revenue and Growth Rate (2015-2020)
7.4 Korea Genomic Biomarker Revenue and Growth Rate (2015-2020)
7.5 India Genomic Biomarker Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Genomic Biomarker Revenue and Growth Rate (2015-2020)
8 South America Genomic Biomarker Revenue by Countries
8.1 South America Genomic Biomarker Revenue by Countries (2015-2020)
8.2 Brazil Genomic Biomarker Revenue and Growth Rate (2015-2020)
8.3 Argentina Genomic Biomarker Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Genomic Biomarker by Countries
9.1 Middle East & Africa Genomic Biomarker Revenue by Countries (2015-2020)
9.2 Saudi Arabia Genomic Biomarker Revenue and Growth Rate (2015-2020)
9.3 UAE Genomic Biomarker Revenue and Growth Rate (2015-2020)
9.4 Egypt Genomic Biomarker Revenue and Growth Rate (2015-2020)
9.5 South Africa Genomic Biomarker Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Genomic Biomarker Revenue and Market Share by Type (2015-2020)
10.2 Global Genomic Biomarker Market Forecast by Type (2019-2024)
10.3 Oncology Revenue Growth Rate (2015-2025)
10.4 Cardiology Revenue Growth Rate (2015-2025)
10.5 Neurology Revenue Growth Rate (2015-2025)
10.6 Nephrology Revenue Growth Rate (2015-2025)
11 Global Genomic Biomarker Market Segment by Application
11.1 Global Genomic Biomarker Revenue Market Share by Application (2015-2020)
11.2 Genomic Biomarker Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic and research laboratories Revenue Growth (2015-2020)
12 Global Genomic Biomarker Market Size Forecast (2021-2025)
12.1 Global Genomic Biomarker Market Size Forecast (2021-2025)
12.2 Global Genomic Biomarker Market Forecast by Regions (2021-2025)
12.3 North America Genomic Biomarker Revenue Market Forecast (2021-2025)
12.4 Europe Genomic Biomarker Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Genomic Biomarker Revenue Market Forecast (2021-2025)
12.6 South America Genomic Biomarker Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Genomic Biomarker Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Genomic Biomarker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Genomic Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Genomic Biomarker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Genomic Biomarker Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bio-Rad Corporate Information, Location and Competitors
Table 6. Bio-Rad Genomic Biomarker Major Business
Table 7. Bio-Rad Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 8. Bio-Rad SWOT Analysis
Table 9. Bio-Rad Genomic Biomarker Product and Solutions
Table 10. Bio-Rad Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Almac Corporate Information, Location and Competitors
Table 12. Almac Genomic Biomarker Major Business
Table 13. Almac Genomic Biomarker Total Revenue (USD Million) (2018-2019)
Table 14. Almac SWOT Analysis
Table 15. Almac Genomic Biomarker Product and Solutions
Table 16. Almac Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 18. Thermo Fisher Scientific Genomic Biomarker Major Business
Table 19. Thermo Fisher Scientific Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 20. Thermo Fisher Scientific SWOT Analysis
Table 21. Thermo Fisher Scientific Genomic Biomarker Product and Solutions
Table 22. Thermo Fisher Scientific Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beckman Coulter Corporate Information, Location and Competitors
Table 24. Beckman Coulter Genomic Biomarker Major Business
Table 25. Beckman Coulter Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 26. Beckman Coulter SWOT Analysis
Table 27. Beckman Coulter Genomic Biomarker Product and Solutions
Table 28. Beckman Coulter Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Epigenomics Corporate Information, Location and Competitors
Table 30. Epigenomics Genomic Biomarker Major Business
Table 31. Epigenomics Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 32. Epigenomics SWOT Analysis
Table 33. Epigenomics Genomic Biomarker Product and Solutions
Table 34. Epigenomics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Myriad Genetics Corporate Information, Location and Competitors
Table 36. Myriad Genetics Genomic Biomarker Major Business
Table 37. Myriad Genetics Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 38. Myriad Genetics SWOT Analysis
Table 39. Myriad Genetics Genomic Biomarker Product and Solutions
Table 40. Myriad Genetics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Human Longevity Corporate Information, Location and Competitors
Table 42. Human Longevity Genomic Biomarker Major Business
Table 43. Human Longevity Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 44. Human Longevity SWOT Analysis
Table 45. Human Longevity Genomic Biomarker Product and Solutions
Table 46. Human Longevity Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. QIAGEN Corporate Information, Location and Competitors
Table 48. QIAGEN Genomic Biomarker Major Business
Table 49. QIAGEN Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 50. QIAGEN SWOT Analysis
Table 51. QIAGEN Genomic Biomarker Product and Solutions
Table 52. QIAGEN Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Genomic Biomarker Major Business
Table 55. Roche Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Genomic Biomarker Product and Solutions
Table 58. Roche Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Genomic Biomarker Major Business
Table 61. Pfizer Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Genomic Biomarker Product and Solutions
Table 64. Pfizer Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Agilent Corporate Information, Location and Competitors
Table 66. Agilent Genomic Biomarker Major Business
Table 67. Agilent Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 68. Agilent SWOT Analysis
Table 69. Agilent Genomic Biomarker Product and Solutions
Table 70. Agilent Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. ValiRx Corporate Information, Location and Competitors
Table 72. ValiRx Genomic Biomarker Major Business
Table 73. ValiRx Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 74. ValiRx SWOT Analysis
Table 75. ValiRx Genomic Biomarker Product and Solutions
Table 76. ValiRx Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Illumina Corporate Information, Location and Competitors
Table 78. Illumina Genomic Biomarker Major Business
Table 79. Illumina Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 80. Illumina SWOT Analysis
Table 81. Illumina Genomic Biomarker Product and Solutions
Table 82. Illumina Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Empire Genomics Corporate Information, Location and Competitors
Table 84. Empire Genomics Genomic Biomarker Major Business
Table 85. Empire Genomics Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 86. Empire Genomics SWOT Analysis
Table 87. Empire Genomics Genomic Biomarker Product and Solutions
Table 88. Empire Genomics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Personalis Corporate Information, Location and Competitors
Table 90. Personalis Genomic Biomarker Major Business
Table 91. Personalis Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 92. Personalis SWOT Analysis
Table 93. Personalis Genomic Biomarker Product and Solutions
Table 94. Personalis Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Eagle Genomics Corporate Information, Location and Competitors
Table 96. Eagle Genomics Genomic Biomarker Major Business
Table 97. Eagle Genomics Genomic Biomarker Total Revenue (USD Million) (2017-2018)
Table 98. Eagle Genomics SWOT Analysis
Table 99. Eagle Genomics Genomic Biomarker Product and Solutions
Table 100. Eagle Genomics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Global Genomic Biomarker Revenue (Million USD) by Players (2015-2020)
Table 102. Global Genomic Biomarker Revenue Share by Players (2015-2020)
Table 103. Global Genomic Biomarker Revenue (Million USD) by Regions (2015-2020)
Table 104. Global Genomic Biomarker Revenue Market Share by Regions (2015-2020)
Table 105. North America Genomic Biomarker Revenue by Countries (2015-2020)
Table 106. North America Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Table 107. Europe Genomic Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 108. Asia-Pacific Genomic Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 109. South America Genomic Biomarker Revenue by Countries (2015-2020)
Table 110. South America Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Table 111. Middle East and Africa Genomic Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 112. Middle East and Africa Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Table 113. Global Genomic Biomarker Revenue (Million USD) by Type (2015-2020)
Table 114. Global Genomic Biomarker Revenue Share by Type (2015-2020)
Table 115. Global Genomic Biomarker Revenue Forecast by Type (2021-2025)
Table 116. Global Genomic Biomarker Revenue by Application (2015-2020)
Table 117. Global Genomic Biomarker Revenue Share by Application (2015-2020)
Table 118. Global Genomic Biomarker Revenue Forecast by Application (2021-2025)
Table 119. Global Genomic Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Genomic Biomarker Picture
Figure 2. Global Genomic Biomarker Revenue Market Share by Type in 2019
Figure 3. Oncology Picture
Figure 4. Cardiology Picture
Figure 5. Neurology Picture
Figure 6. Nephrology Picture
Figure 7. Genomic Biomarker Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Diagnostic and research laboratories Picture
Figure 10. Global Genomic Biomarker Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Genomic Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Genomic Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Genomic Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Genomic Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Genomic Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Genomic Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Genomic Biomarker Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Genomic Biomarker Revenue Market Share in 2019
Figure 19. Global Top 10 Players Genomic Biomarker Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Genomic Biomarker Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Genomic Biomarker Revenue Market Share by Regions (2015-2020)
Figure 23. Global Genomic Biomarker Revenue Market Share by Regions in 2018
Figure 24. North America Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 25. Europe Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 27. South America Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 29. North America Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Figure 30. North America Genomic Biomarker Revenue Market Share by Countries in 2019
Figure 31. USA Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 32. Canada Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 34. Europe Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Genomic Biomarker Revenue Market Share by Countries in 2019
Figure 36. Germany Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 37. UK Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 38. France Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 39. Russia Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 40. Italy Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Genomic Biomarker Revenue Market Share by Countries in 2019
Figure 43. China Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 44. Japan Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 45. Korea Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 46. India Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 48. South America Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Figure 49. South America Genomic Biomarker Revenue Market Share by Countries in 2019
Figure 50. Brazil Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Genomic Biomarker Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Genomic Biomarker Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 55. UAE Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Genomic Biomarker Revenue and Growth Rate (2015-2020)
Figure 58. Global Genomic Biomarker Revenue Share by Type (2015-2020)
Figure 59. Global Genomic Biomarker Revenue Share by Type in 2019
Figure 60. Global Genomic Biomarker Market Share Forecast by Type (2021-2025)
Figure 61. Global Oncology Revenue Growth Rate (2015-2020)
Figure 62. Global Cardiology Revenue Growth Rate (2015-2020)
Figure 63. Global Neurology Revenue Growth Rate (2015-2020)
Figure 64. Global Nephrology Revenue Growth Rate (2015-2020)
Figure 65. Global Genomic Biomarker Revenue Share by Application (2015-2020)
Figure 66. Global Genomic Biomarker Revenue Share by Application in 2019
Figure 67. Global Genomic Biomarker Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostic and research laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global Genomic Biomarker Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Genomic Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Genomic Biomarker Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Genomic Biomarker Revenue Market Forecast (2021-2025)
Figure 74. Europe Genomic Biomarker Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Genomic Biomarker Revenue Market Forecast (2021-2025)
Figure 76. South America Genomic Biomarker Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Genomic Biomarker Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
バイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.2% in the forecast period of 2020 to 2025 and will expected to reach USD 42540 million by 2025, from USD 26890 million in 2019. The Biomarker market report pro…- 心臓バイオマーカーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cardiac Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cardiac Biomarker market re…
- メタボロミクスバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metabolomics Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metabolomics Biomarker…
- がん腫瘍プロファイリングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Tumor Profiling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 54970 million by 2025, from USD 37570 million in 2019. The Cancer Tumor P…
- 前立腺がん診断の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Prostate Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15640 million by 2025, from USD 11940 million in 2019. The Pr…